In the debate over optimal frontline strategies for EGFR-mutant NSCLC with brain metastases, one side advocated for a chemotherapy-based combination approach. Their argument centered on 3 core points: the disrupted blood-brain barrier in patients wit... [1882 chars].. reed more
